Manufacture Advanced Medicine

The Future Awakens

Experts in the cell and gene therapy space are excited about things to come. And why should they not be? After all, these are the pioneers of a burgeoning field of medicine.

11/30/2023 | News

sponsored by Eppendorf, Millipore Sigma, Thermo Fisher Scientific & Miltenyi Biotec

The Medicine Maker’s annual cell and gene supplement returns with a league of extraordinary professionals sharing their insight on how they expect the industry to develop, whilst exercising an optimistic caution for the future of this still young area of expertise. Topics discussed include CRISPR, AI, regulated supply chains, and the important role of accurate information regarding new therapies. Illustrious names joining the discussion include Eric Rhodes, ERS Genomics; Monika Paul, Caszyme; Sumukhi Sreevatsan, IMAPAC; Vered Caplan, Orgenesis; and Chelsea Pratt, Bio-Rad Laboratories. Also in the supplement:

Investor enthusiasm versus the economic crisis
Juggling industry with academia
Sitting Down With Tirtha Chakraborty

Get ready for the future. Download the supplement here

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.